These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17672129)

  • 1. [Bordetella pertussis agglutinogens in cultivation dynamics].
    Basnak'ian IA; Aleksakhina NN; Shelemekh OV; Miriasova LV; Siundiukova RA
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (3):37-42. PubMed ID: 17672129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pertussis toxin and cross-reactive antigens in dynamics of Bordetella pertussis cultivation].
    Basnak'ian IA; Aleksakhina NN; Siundiukova SA; Zakharova NS; Zaĭtsev EM; Iastrebova NE; Vaneeva NP
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (5):54-7. PubMed ID: 18038548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Western blot analysis of antibody responses of young infants to pertussis infection.
    Guiso N; Grimprel E; Anjak I; Bégué P
    Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):596-600. PubMed ID: 8223658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serospecific protection of mice against intranasal infection with Bordetella pertussis.
    Robinson A; Gorringe AR; Funnell SG; Fernandez M
    Vaccine; 1989 Aug; 7(4):321-4. PubMed ID: 2573215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The specificity of antisera against Bordetella pertussis examined by bacterial agglutination.
    Fredriksen JH; Frøholm LO; Kjennerud U
    Acta Pathol Microbiol Immunol Scand B; 1987 Dec; 95(6):363-9. PubMed ID: 2894108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crucial role of antibodies to pertactin in Bordetella pertussis immunity.
    Hellwig SM; Rodriguez ME; Berbers GA; van de Winkel JG; Mooi FR
    J Infect Dis; 2003 Sep; 188(5):738-42. PubMed ID: 12934190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of linear epitopes of pertussis toxin using overlapping synthetic decapeptides: identification of a human B-cell determinant in the S1 subunit indicative of acute infections.
    Raupach B; Schmidt MA
    Microb Pathog; 1994 Oct; 17(4):213-26. PubMed ID: 7536288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
    Thomas MG; Ashworth LA; Miller E; Lambert HP
    J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory IgA against pertussis toxin and surface structures of Bordetella pertussis in saliva of children with culture proven pertussis.
    Frühwirth M; Wolf H; Heininger H; Guggenbichler JP; Stehr E
    Adv Exp Med Biol; 1995; 371B():777-83. PubMed ID: 7502896
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of pertactin in pertussis vaccines: the jury is still out.
    Desauziers E; Danve B; Decker MD; Veitch K
    J Infect Dis; 2004 Apr; 189(7):1332-3; author reply 1333-5. PubMed ID: 15031804
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents.
    Hodder SL; Cherry JD; Mortimer EA; Ford AB; Gornbein J; Papp K
    Clin Infect Dis; 2000 Jul; 31(1):7-14. PubMed ID: 10913389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses.
    Jackson LA; Cherry JD; Wang SP; Grayston JT
    Clin Infect Dis; 2000 Jul; 31(1):3-6. PubMed ID: 10913388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chick embryo, a model to study the lethal activity of pertussis toxin, infectivity of Bordetella pertussis, and their neutralization by immune sera.
    Calver GA; Burton WW; Gardell CY
    Can J Microbiol; 1993 Aug; 39(8):759-66. PubMed ID: 8106134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitfalls in the preparation of monotypic agglutinating antisera for Bordetella pertussis.
    Holt LB
    J Med Microbiol; 1968 Nov; 1(2):169-80. PubMed ID: 4318535
    [No Abstract]   [Full Text] [Related]  

  • 15. Specific anti-Bordetella pertussis activities in human blood examined by enzyme-linked immunoassay and biological assay.
    Marley PB; Wilson JV; Habel H; Blaskett A
    Dev Biol Stand; 1985; 61():341-52. PubMed ID: 2872123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal.
    Relyveld E; Oato NH; Guérin N; Coursaget P; Huet M; Gupta RK
    Vaccine; 1991 Nov; 9(11):843-50. PubMed ID: 1759508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Components of acellular pertussis vaccines.
    Preston NW; Matthews RC
    Lancet; 1996 Mar; 347(9003):764. PubMed ID: 8602023
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute Bordetella pertussis infection in an adult.
    Smith S; Tilton RC
    J Clin Microbiol; 1996 Feb; 34(2):429-30. PubMed ID: 8789030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stainer and Scholte's pertussis medium with an alternative buffer.
    Lothe RA; Frøholm LO; Westre G; Kjennerud U
    J Biol Stand; 1985 Apr; 13(2):129-34. PubMed ID: 2860114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Humoral response to the injection of acellular Pertussis vaccine].
    Zakharova NS; Remova TN; Britsina MV; Shmeleva EI; Mertsalova NU; Zaĭtsev EM; Ozeretskovskaia MN; Bazhanova IG; Ermolova EV
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (6):40-4. PubMed ID: 11881494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.